LA VANGUARDIA: ¿Estudiar lesiones medulares sin recurrir a la experimentación animal?
El proyecto utilizará organoides creados a partir de células madre para reproducir lesiones medulares en condiciones similares a las humanas.
El proyecto utilizará organoides creados a partir de células madre para reproducir lesiones medulares en condiciones similares a las humanas.
El Institut de Bioenginyeria de Catalunya, el primer centro español en obtener la certificación ‘laboratorio verde’, relata cómo ha transformado su actividad para reducir su gasto energético y mejorar su gestión de residuos. El centro fomenta la reflexión sobre la necesidad de los viajes científicos y propone alternativas virtuales o destinos accesibles para reducir la huella de carbono. Catalunya desplegará una iniciativa pionera para reducir la huella ambiental de todos sus centros de investigación.
Un estudio liderado por el Instituto de Bioingeniería de Cataluña (IBEC) ha descubierto que la barrera hematoencefálica, que protege el cerebro de sustancias dañinas, no se define solo por las proteínas que tiene, sino también por cómo las utiliza y renueva.
The research, led by the Institute for Bioengineering of Catalonia, reveals that the blood–brain barrier is defined not only by the proteins it expresses, but by how it uses them, through a dynamic property known as endocytic turnover rate (ETOR). This discovery shows that brain endothelial cells have a unique molecular behaviour that distinguishes them from other blood vessels and can be disrupted during inflammation. The results provide new insight into how the barrier functions and fails in disease which may help identify novel therapeutic strategies to restore neurovascular health.
In June, the IBEC management team took part in an exchange visit to the UCL Hawkes Institute as part of the Severo Ochoa programme. Currently in its pilot phase, this initiative opens up new opportunities for knowledge and best practice sharing in research management amongst leading international institutions.
On 18 June, the results were announced for the 36 research projects funded by La Marató de 3Cat through its 2020 special call for proposals dedicated to tackling the novel coronavirus (SARS-CoV-2). The Institute for Bioengineering of Catalonia (IBEC) participated in three of these projects, which aimed to deepen our understanding of the disease and improve its diagnosis and clinical monitoring.
On Thursday 18 June, IBEC held an event called “IBEC Alumni – 20 Years of Community” at the Barcelona Science Park. Around 100 people attended, including former members and staff of the institute. The event aimed to reconnect the alumni community, share career journeys, and showcase the talent nurtured at IBEC over the last 20 years.
Over 200 people took part in IBEC Day 2026, an event designed to encourage sharing, connection and celebration in honour of the institute’s 20th anniversary.
The prize recognises the research work of Sánchez, ICREA Research Professor at IBEC. These awards, presented by the Valencian Foundation Rei Jaume I Awards, aim to bring science and business closer together in order to promote research, scientific development and entrepreneurship in Spain.
The Institute for Bioengineering of Catalonia (IBEC) has secured over €27 million in Horizon Europe funding for the period 2021–2024, thus consolidating its position as one of Spain’s leading centres. IBEC ranks fifth among research centres in terms of return on investment and seventh among national entities in terms of ERC funding. This success is underpinned by a project management model that combines scientific excellence with robust support for securing European funding.